Relenza (Zanamivir) News and Research

RSS
Relenza (zanamivir) is an anti-viral drug, for persons aged 7 years and older for the treatment of uncomplicated influenza illness. This product is approved to treat type A and B influenza, the two types most responsible for flu epidemics. Clinical studies showed that for the drug to be effective, patients needed to start treatment within two days of the onset of symptoms. The drug seemed to be less effective in patients whose symptoms weren't severe or didn't include a fever. Relenza is approved for preventive use, to decrease the risk of developing influenza illness, for persons aged 5 and older. Relenza is a powder that is inhaled twice a day for five days from a breath-activated plastic device called a Diskhaler for treatment of influenza. For preventive use to reduce the risk of getting influenza, Relenza is inhaled once daily for 10 to 28 days as prescribed by a healthcare provider.
WHO warns Aussies to prepare for deadly flu

WHO warns Aussies to prepare for deadly flu

Amantadine and rimantadine for influenza A in children and the elderly

Amantadine and rimantadine for influenza A in children and the elderly

Brits gear up for pandemic while FDA warns about flu jabs side-effects

Brits gear up for pandemic while FDA warns about flu jabs side-effects

Biota increases damages claim against GlaxoSmithKline

Biota increases damages claim against GlaxoSmithKline

HHS and BioCryst advance development of new influenza drug

HHS and BioCryst advance development of new influenza drug

New bird flu drug will provide new line of defence

New bird flu drug will provide new line of defence

Experts say Britain vulnerable to bird flu pandemic

Experts say Britain vulnerable to bird flu pandemic

Chink in the armour of H5N1 bird flu virus

Chink in the armour of H5N1 bird flu virus

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

Neuraminidase inhibitors for preventing and treating influenza in healthy adults

Brits to trial bird flu vaccine on humans

Brits to trial bird flu vaccine on humans

Renewed interest in studying influenza A viruses

Renewed interest in studying influenza A viruses

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

U.S. buys more Relenza and Tamiflu for future influenza pandemics

U.S. buys more Relenza and Tamiflu for future influenza pandemics

Two drug giants team up to develop new bird flu therapy

Two drug giants team up to develop new bird flu therapy

Tamiflu alone won't work in bird flu pandemic

Tamiflu alone won't work in bird flu pandemic

Experts demand more funds to stop the spread of bird flu

Experts demand more funds to stop the spread of bird flu

US warns older flu drugs often don't work

US warns older flu drugs often don't work

Aussies get $185m injection to fight bird flu

Aussies get $185m injection to fight bird flu

Indonesia to produce bird flu vaccine with help from U.S. company

Indonesia to produce bird flu vaccine with help from U.S. company

Star anise sought after in bird flu fight

Star anise sought after in bird flu fight